Free Trial

Belite Bio (BLTE) Competitors

Belite Bio logo
$56.81 -0.35 (-0.61%)
Closing price 04:00 PM Eastern
Extended Trading
$59.71 +2.90 (+5.10%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BLTE vs. RVMD, ELAN, LEGN, GRFS, TLX, TGTX, LNTH, NUVL, AXSM, and AKRO

Should you be buying Belite Bio stock or one of its competitors? The main competitors of Belite Bio include Revolution Medicines (RVMD), Elanco Animal Health (ELAN), Legend Biotech (LEGN), Grifols (GRFS), Telix Pharmaceuticals (TLX), TG Therapeutics (TGTX), Lantheus (LNTH), Nuvalent (NUVL), Axsome Therapeutics (AXSM), and Akero Therapeutics (AKRO). These companies are all part of the "pharmaceutical products" industry.

Belite Bio vs. Its Competitors

Revolution Medicines (NASDAQ:RVMD) and Belite Bio (NASDAQ:BLTE) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Belite Bio has lower revenue, but higher earnings than Revolution Medicines. Belite Bio is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution Medicines$11.58M598.22-$600.09M-$4.00-9.30
Belite BioN/AN/A-$36.14M-$1.36-41.77

In the previous week, Revolution Medicines had 12 more articles in the media than Belite Bio. MarketBeat recorded 14 mentions for Revolution Medicines and 2 mentions for Belite Bio. Belite Bio's average media sentiment score of 1.11 beat Revolution Medicines' score of 0.73 indicating that Belite Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revolution Medicines
4 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Belite Bio
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Revolution Medicines has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Belite Bio has a beta of -1.5, meaning that its stock price is 250% less volatile than the S&P 500.

Revolution Medicines currently has a consensus target price of $67.58, indicating a potential upside of 81.72%. Belite Bio has a consensus target price of $96.67, indicating a potential upside of 70.16%. Given Revolution Medicines' higher possible upside, research analysts plainly believe Revolution Medicines is more favorable than Belite Bio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revolution Medicines
0 Sell rating(s)
0 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
3.00
Belite Bio
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

94.3% of Revolution Medicines shares are held by institutional investors. Comparatively, 0.5% of Belite Bio shares are held by institutional investors. 8.2% of Revolution Medicines shares are held by insiders. Comparatively, 13.3% of Belite Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Belite Bio's return on equity of -32.07% beat Revolution Medicines' return on equity.

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A -37.06% -32.84%
Belite Bio N/A -32.07%-30.91%

Summary

Revolution Medicines beats Belite Bio on 7 of the 13 factors compared between the two stocks.

Get Belite Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLTE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLTE vs. The Competition

MetricBelite BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.82B$2.88B$5.54B$8.87B
Dividend YieldN/A2.64%5.39%4.10%
P/E Ratio-41.7721.3126.1719.90
Price / SalesN/A278.47414.67113.66
Price / CashN/A41.4736.1356.90
Price / Book12.047.518.055.38
Net Income-$36.14M-$55.05M$3.15B$248.50M
7 Day Performance-7.02%2.45%1.85%2.97%
1 Month Performance-12.63%7.33%4.81%6.02%
1 Year Performance24.86%5.38%34.86%20.39%

Belite Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLTE
Belite Bio
2.5018 of 5 stars
$56.81
-0.6%
$96.67
+70.2%
+24.7%$1.82BN/A-41.7710High Trading Volume
RVMD
Revolution Medicines
4.4934 of 5 stars
$40.04
+1.0%
$67.08
+67.5%
-4.9%$7.39B$11.58M-10.01250Analyst Revision
ELAN
Elanco Animal Health
2.3246 of 5 stars
$13.36
-0.7%
$15.17
+13.5%
+2.5%$6.68B$4.44B18.059,000Analyst Forecast
LEGN
Legend Biotech
3.34 of 5 stars
$33.85
-0.4%
$76.20
+125.1%
-21.1%$6.25B$627.24M-57.372,609Positive News
Analyst Forecast
GRFS
Grifols
4.1298 of 5 stars
$8.37
-4.6%
$10.30
+23.1%
+43.3%$6.03B$7.81B7.1523,822Analyst Downgrade
TLX
Telix Pharmaceuticals
N/A$16.39
-4.4%
$22.00
+34.2%
N/A$5.80B$516.72M0.00N/AGap Down
High Trading Volume
TGTX
TG Therapeutics
3.7651 of 5 stars
$36.56
+1.5%
$40.80
+11.6%
+95.0%$5.72B$329M152.33290
LNTH
Lantheus
4.4467 of 5 stars
$80.81
+2.0%
$130.50
+61.5%
-0.7%$5.48B$1.53B22.96700Positive News
NUVL
Nuvalent
3.7277 of 5 stars
$75.98
+1.3%
$115.50
+52.0%
+3.3%$5.39BN/A-17.3140Analyst Upgrade
Insider Trade
AXSM
Axsome Therapeutics
4.6769 of 5 stars
$101.65
+1.0%
$172.33
+69.5%
+27.1%$4.96B$385.69M-17.62380Analyst Revision
AKRO
Akero Therapeutics
3.6224 of 5 stars
$54.03
-0.3%
$82.50
+52.7%
+122.0%$4.32BN/A-27.7130

Related Companies and Tools


This page (NASDAQ:BLTE) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners